New Customs Requirements Set to Disrupt Canadian Prescription Imports October 22
The Wall Street Journal reports that new customs requirements taking effect October 22, 2026, could disrupt access to prescription drugs for millions of Americans who purchase medications from Canadian and other foreign mail-order pharmacies. The change affects individuals who rely on imported pharmaceuticals for cost savings. The timing and scope of enforcement will determine how many consumers and which medication categories face immediate supply interruptions. For Medicaid programs, this could increase formulary pressure if beneficiaries who previously self-paid for imported drugs now seek coverage through state plans, and may affect dual-eligible populations managing Medicare Part D coverage gaps.
State Medicaid agencies may face increased prescription volume and costs if beneficiaries previously buying imported drugs shift to state-covered formularies after losing access to foreign mail-order sources.
Pharmacy
You might also like